Abstract
Background Multiple observational studies have reported associations between greater parity and increased CVD risk. Whether these associations reflect causal effects or are confounded by socioeconomic factors remains unclear.
Methods We investigated associations between number of children ever born (NEB) and 16 cardiometabolic traits in up to 172,122 females and 138,390 males in the UK Biobank, and an independent sample of 53,237 UK Biobank spousal pairs. We additionally conducted sex-stratified two-sample Mendelian randomization (MR) and applied a novel spousal MR framework, in which an individual’s spouse’s genotype was used as the instrumental variable to estimate the causal effect of NEB on cardiometabolic health outcomes, as an approach to minimize bias from horizontal pleiotropy.
Results NEB was associated with multiple cardiometabolic traits in the multivariable regression, even after adjustment for socioeconomic status, with differences in the strength of association observed between males and females. Traditional MR provided evidence that higher NEB causally increases type 2 diabetes risk in females, body mass index (BMI) in both sexes, female basal metabolic rate (BMR) and male body fat percentage but decreases female blood pressure. Spousal MR corroborated positive effects on female BMI and BMR and additionally suggested inverse causal effects on female HDL cholesterol and ApoA1 and male blood glucose.
Conclusion These findings indicate a possible causal relationship between NEB and long term cardiometabolic health, although causal effects are likely to be small.
Competing Interest Statement
The authors have declared no competing interest.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study utilized data from the UK Biobank. The UK Biobank has ethical approval from the North West Multi-Centre Research Ethics Committee (MREC), which covers the UK, and all participants provided written informed consent (REC reference: 21/NW/0157). This research has been conducted using the UK Biobank resource under application number 53641. This project received ethical approval from the Institutional Human Research Ethics committee, University of Queensland (Approval Number 2019002705).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵# Joint last
Funder Information Declared
